# OnCo record tscan (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/tscan/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "tscan" ;
  schema:name "TScan Therapeutics"@en ;
  schema:description "TCR discovery company that cut 75% of staff in September 2026 to focus on in vivo-engineered TCR-T for solid tumours (PRAME, MAGE-A4)."@en ;
  schema:url <https://onco.cc/companies/tscan/>, <https://www.tscan.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.biospace.com/press-releases/tscan-therapeutics-announces-strategic-reorganization-to-focus-on-in-vivo-cell-therapy-for-solid-tumors> ;
  onco:tag "pivot" ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/tcr-t/>, <https://onco.cc/technologies/in-vivo-car-t/> ;
  onco:targets <https://onco.cc/targets/mage-a4/> .